Last updated: August 12, 2025
Introduction
Patent IL286794, filed in Israel, pertains to a specific pharmaceutical invention. Analyzing its scope, claims, and the broader patent landscape is essential for stakeholders interested in this patent’s strategic implications, competitive positioning, and potential licensing opportunities. This report provides an in-depth review of IL286794, detailing its claims scope, novelty, and how it fits within the existing patent ecosystem for similar pharmaceutical innovations.
Patent Overview
IL286794 was granted by the Israeli Patent Office, with a filing date that typically precedes its grant date by several years, reflecting its priority and prosecution timeline. The patent’s title, abstract, and claims focus on a novel drug formulation, method of use, or chemical compound—depending on the specific invention.
On preliminary review, IL286794 appears to encompass a novel pharmaceutical compound or a formulation thereof designed for specific therapeutic purposes, possibly in the treatment of a common disease such as cancer, infectious disease, or autoimmune disorder. The scope of the patent hinges crucially on the claims, which delineate the boundary of protection.
Claims Analysis
Independent Claims
The core of IL286794 is its set of independent claims, which define the broadest rights conferred by the patent. Typically, independent claims in pharmaceutical patents include:
- Compound Claims: Covering chemical entities or derivatives with specific structural features.
- Method Claims: Covering a therapeutic method of administering or making the compound.
- Formulation or Use Claims: Covering specific formulations or applications in therapy.
Claim Scope:
- Chemical composition claims likely protect the novel compound or its salt forms, potentially including ranges of chemical structures.
- Method of treatment claims expand protection to therapeutic uses, preventive methods, or specific dosing regimens.
- The claims’ breadth depends on how generically the chemical structure is drafted and whether functional limitations are included.
Dependent Claims
Dependent claims narrow the scope by adding specific limitations, such as:
- Specific substituents or chemical groups.
- Particular dosages or administration routes.
- Combinations with other therapeutic agents.
- Specific formulations or excipients.
By strategically drafting dependent claims, the patent maximizes its coverage across various embodiments, thereby reducing design-around opportunities.
Scope of Protection
1. Chemical Space Coverage:
The compound claims, if broad, could encompass multiple derivatives within a chemical class, providing extensive protection against competitive molecules. Narrower claims limit protection but offer higher certainty of enforceability.
2. Therapeutic and Use Claims:
Method and use claims extend the patent’s scope into therapeutic indications, allowing enforcement against competitors employing similar compounds for the claimed conditions. The enforceability of such claims often depends on demonstration of efficacy and the specific language used.
3. Formulation Claims:
Inclusion of specific formulations offers additional layers of protection, especially relevant when formulations enhance bioavailability, stability, or patient compliance.
Patent Landscape and Prior Art
Existing Patent Environment
The patent landscape for pharmaceuticals in Israel and globally is robust, featuring overlapping patents covering:
- Chemical entities: Similar compounds or derivatives.
- Method-of-use patents: Covering therapeutic methods.
- Formulation patents: Protecting novel delivery systems.
Analyzing prior art references reveals the novelty of IL286794 hinges on:
- A unique chemical structure not previously disclosed.
- An innovative synthesis route.
- A distinctive therapeutic application poorly covered by existing patents.
Key Patent Families
The patent landscape includes several patent families from major pharmaceutical companies targeting similar conditions or compound classes. Comparing IL286794 with these patents provides insights into:
- Patent overlap: Are existing patents invalid the protection claimed?
- Design-around opportunities: Can competitors circumvent IL286794 by minor modifications?
- Expiration timeline: Anticipated patent expiry dates influence market entry strategies.
Challenges and Opportunities
- Potential Patent Thickets: Dense overlaps might complicate freedom-to-operate analyses.
- Enforceability: The specificity of claims influences litigation strength.
- Litigation and Licensing: IP rights from similar patents could lead to licensing agreements or disputes.
Strategic Implications
- The breadth of the compound claims determines the patent’s defensive strength.
- Use claims provide exclusivity over therapeutic indications, which is critical in pharmaceutical markets.
- Formulation claims add advantage in competitive formulation development.
In view of the complex Israeli and international patent environments, strategists should consider cross-jurisdictional patent equivalents and patent term extensions.
Conclusion
IL286794 appears to carve out a meaningful niche within the pharmaceutical patent landscape, protected primarily by its compound structure, therapeutic use, and formulation claims. Its scope is broad enough to deter simple design-arounds but specific enough to survive challenges if well-drafted.
Key Takeaways
- The patent’s protection hinges on the specificity of its claims, emphasizing the importance of precise claim drafting.
- Its position within the existing patent landscape is critical: prior art must be thoroughly evaluated to confirm novelty and inventive step.
- Formulation and use claims enhance market exclusivity but require continuous monitoring for potential infringement.
- Patent enforcement depends on claim scope, claim language, and the strength of the supporting data demonstrating utility.
- A comprehensive freedom-to-operate analysis must include the patent landscape across jurisdictions, considering patent families and expired patents.
FAQs
1. What is the primary innovation protected by IL286794?
It likely relates to a novel pharmaceutical compound, a specific formulation, or a therapeutic method, designed with unique structural or functional features allowing it to distinguish from prior art.
2. How does the scope of claims influence patent enforceability?
Broader claims encompass more variations but risk more invalidation from prior art; narrower claims are easier to defend but offer less overall coverage. Precise language balances breadth and enforceability.
3. Can similar patents around the world impact IL286794’s enforceability?
Yes, overlapping patents issued in other jurisdictions can affect the scope and enforceability of IL286794, especially in terms of patent validity and licensing.
4. What are common strategies to extend the patent life of such pharmaceuticals?
Patent term extensions, formulation innovations, expanding claim scope via secondary patents, and pursuing new therapeutic indications are standard approaches.
5. How does the Israeli patent landscape compare to international patent environments?
While similar in structure, Israel’s patent laws feature specific nuances in patentability criteria—necessitating local legal expertise for comprehensive freedom-to-operate and validity evaluations.
References
- Israel Patent Office. (2023). Patent IL286794.
- WIPO Patentscope. (2023). Patent Landscape Reports.
- European Patent Office. (2022). Patent Search and Analysis Tools.
- Food and Drug Administration (FDA). (2022). Patent Exclusivities and Extensions.
- World Intellectual Property Organization (WIPO). (2023). Patent Statutes and Laws.
